New Perspectives in Vitiligo Treatment: Emerging Therapies and Novel Medications
DOI:
https://doi.org/10.36557/2674-8169.2024v6n4p2042-2054Keywords:
Vitiligo; Treatment; Emerging.Abstract
The treatment through innovative therapies for vitiligo represents an advanced approach to dealing with this dermatological condition that can significantly affect patients' self-esteem and quality of life. These therapies offer valuable alternatives for those who do not respond adequately to conventional treatments or other available interventions. However, choosing the most suitable therapy is crucial as there are several options available, including different formulations and administration regimens.
Each of these options has its own technical requirements and clinical considerations, and it is essential to examine these differences to assist healthcare professionals and patients in making informed decisions. When exploring different options for innovative therapies for vitiligo, it is important to consider not only effectiveness in terms of skin repigmentation but also factors such as safety, tolerability, and impact on quality of life.
Furthermore, it is necessary to evaluate the overall outcome of patients after the initiation of therapy, including patient adherence, side effects, and satisfaction with treatment. This comprehensive assessment can provide valuable insights into the impact of therapy on daily life and the well-being of patients.
Another important aspect to consider is the customization of treatment, taking into account individual patient needs and preferences, as well as their specific clinical condition. This may involve a careful evaluation of the patient's medical history, their expectations regarding treatment, and their lifestyle. By adopting a patient-centered approach, healthcare professionals can ensure that the chosen therapy meets specific needs and provides the best possible results.
In summary, studying and understanding the options for innovative therapies for vitiligo and their overall outcome assessment are essential to ensure treatment success and patient satisfaction. By considering a variety of factors, from clinical effectiveness to impact on quality of life, healthcare professionals can make more informed and personalized decisions, thereby improving care and outcomes for patients with this dermatological condition.
Downloads
References
Chen, P. H. et al. (2023). Melanocyte transplantation to skin prepared by controlled PUVA-induced sunburn-like blistering for vitiligo treatment – A pilot clinical trial. Journal of the Formosan Medical Association.
Ghashghaei, S. et al. (2023). Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments. Cell Journal, 143-157.
Inoue, S. et al. (2023). JAK inhibitors for the treatment of vitiligo. Journal of Dermatological Science.
Iwanowski, T. et al. (2023). Etiopathogenesis and Emerging Methods for Treatment of Vitiligo. International Journal of Molecular Sciences, 24, 9749.
Khanna, U., & Khandpur, S. (2019). What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo? Review Article. Indian Dermatology Online Journal, 10(3).
Pala, V., Ribero, S., Quaglino, P., & Mastorino, L. (2023). Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics. Journal of Clinical Medicine, 12, 7486.
Perez-Bootello, J., Cova-Martin, R., Naharro-Rodriguez, J., & Segurado-Miravalles, G. (2023). Vitiligo: Pathogenesis and New and Emerging Treatments. International Journal of Molecular Sciences, 24, 17306.
Rosmarin, D. et al. (2020). Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. The Lancet, 396.
Rosmarin, D. et al. (2022). Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. New England Journal of Medicine, 387(16).
Yang, R.-l., et al. (2023). Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo. Frontiers in Cell and Developmental Biology, 11:129310.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maria Gabrielle Dutra Martinez Emerick, Giovanna Santi Camara, Mariana Santos Santana , Ana Carolina de Lima Silva , Luiza Festugato Cunha

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



